Search research articles
Contact Us
Filters
Showing results (131-140 of 289) with videos related to
Page
of 29
Sort By:
Clinical Genitourinary Cancer
|
June 11, 2019
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population
Giorgia Peverelli, Alessandra Raimondi, Raffaele Ratta, et al.
Cancer Treatment Reviews
|
June 24, 2020
Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes
Mélanie Claps, Alessia Mennitto, Valentina Guadalupi, et al.
Oncology and Therapy
|
May 1, 2025
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment Pathway
Stefania Gori, Alessandra Fabi, Giuseppe Procopio, et al.
Frontiers in Oncology
|
December 13, 2021
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)
Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, et al.
Expert Review of Anticancer Therapy
|
May 6, 2026
¹⁷⁷lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer
Carolina Sciortino, Amedeo Nuzzo, Marco Stellato, et al.
The Oncologist
|
March 15, 2019
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)
Manuela Schmidinger, Aristotelis Bamias, Giuseppe Procopio, et al.
Diagnostics (Basel, Switzerland)
|
February 11, 2023
The Role of CT Imaging in Characterization of Small Renal Masses
Maria Vittoria Bazzocchi, Carlotta Zilioli, Vita Ida Gallone, et al.
American Journal of Clinical Oncology
|
September 12, 2018
Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program
Michele Prisciandaro, Raffaele Ratta, Francesco Massari, et al.
Tumori
|
January 14, 2017
Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience
Alberto De Gobbi, Davide Biasoni, Mario Catanzaro, et al.
BMC Cancer
|
June 24, 2024
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma - Meet-URO 33 study (REGAL study)
Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, et al.
Page
of 29
Search research articles
Search
Showing results (131-140 of 289) with videos related to
Sort By:
Page
of 29
Clinical Genitourinary Cancer
|
June 11, 2019
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population
Giorgia Peverelli, Alessandra Raimondi, Raffaele Ratta, et al.
Cancer Treatment Reviews
|
June 24, 2020
Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes
Mélanie Claps, Alessia Mennitto, Valentina Guadalupi, et al.
Oncology and Therapy
|
May 1, 2025
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment Pathway
Stefania Gori, Alessandra Fabi, Giuseppe Procopio, et al.
Frontiers in Oncology
|
December 13, 2021
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)
Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, et al.
Expert Review of Anticancer Therapy
|
May 6, 2026
¹⁷⁷lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer
Carolina Sciortino, Amedeo Nuzzo, Marco Stellato, et al.
The Oncologist
|
March 15, 2019
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)
Manuela Schmidinger, Aristotelis Bamias, Giuseppe Procopio, et al.
Diagnostics (Basel, Switzerland)
|
February 11, 2023
The Role of CT Imaging in Characterization of Small Renal Masses
Maria Vittoria Bazzocchi, Carlotta Zilioli, Vita Ida Gallone, et al.
American Journal of Clinical Oncology
|
September 12, 2018
Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program
Michele Prisciandaro, Raffaele Ratta, Francesco Massari, et al.
Tumori
|
January 14, 2017
Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience
Alberto De Gobbi, Davide Biasoni, Mario Catanzaro, et al.
BMC Cancer
|
June 24, 2024
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma - Meet-URO 33 study (REGAL study)
Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, et al.
Page
of 29